A poll commissioned by TheraPsil has found that 56 per cent of Canadians approve of legalizing psilocybin therapy for treatment-resistant depression (TRD) and almost two-thirds, 64 per cent, approve of legalizing psilocybin for individuals who have a terminal illness.
Conducted by Pollara Strategic Insights in October, more than 1,500 Canadians were surveyed, with results weighted based on age, gender and region.
Share this post
